Evidence map›Paper›PMID 36631694›Full record

ArticleHealth care management science2023

Machine learning for optimal test admission in the presence of resource constraints.

Ramy Elitzur, Dmitry Krass, Eyal Zimlichman

Abstract read
In one paragraph

Article in Health care management science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ramy Elitzur *Rotman School of Management, University of Toronto, 105 St. George St., Toronto, ON, M5S 3E6, Canada. ramy.elitzur@rotman.utoronto.ca.
Dmitry Krass *Rotman School of Management, University of Toronto, 105 St. George St., Toronto, ON, M5S 3E6, Canada.ORCID http://orcid.org/0000-0001-8243-2509
Eyal Zimlichman *Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Funding

Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada 2015-05904
6 · The paper itself

Abstract

Developing rapid tools for early detection of viral infection is crucial for pandemic containment. This is particularly crucial when testing resources are constrained and/or there are significant delays until the test results are available - as was quite common in the early days of Covid-19 pandemic. We show how predictive analytics methods using machine learning algorithms can be combined with optimal pre-test screening mechanisms, greatly increasing test efficiency (i.e., rate of true positives identified per test), as well as to allow doctors to initiate treatment before the test results are available. Our optimal test admission policies account for imperfect accuracy of both the medical test and the model prediction mechanism. We derive the accuracy required for the optimized admission policies to be effective. We also show how our policies can be extended to re-testing high-risk patients, as well as combined with pool testing approaches. We illustrate our techniques by applying them to a large data reported by the Israeli Ministry of Health for RT-PCR tests from March to September 2020. Our results demonstrate that in the context of the Covid-19 pandemic a pre-test probability screening tool with conventional RT-PCR testing could have potentially increased efficiency by several times, compared to random admission control.

Indexed as

COVID-19HospitalizationHumansMachine LearningPandemicsSARS-CoV-2Data analyticsMachine learningOptimal test admission policiesPredictive analytics

Identifiers

PMID36631694
PMCPMC9838546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.